Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Trial
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Shoujiang You, Xia Wang, Richard I. Lindley, Thompson Robinson, Craig S. Anderson, Yongjun Cao, John Chalmers
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (2017) 44 (5-6): 320–324.
Published Online: 26 October 2017
... among participants of the pilot phase, Intensive Blood Pressure (BP) Reduction in Acute Cerebral Hemorrhage Trial (INTERACT1). Methods: INTERACT1 was an open randomized trial of early intensive (target systolic BP <140 mm Hg) compared with contemporaneous guideline-recommended BP lowering in 404...
Journal Articles
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (2013) 35 (Suppl. 1): 8–17.
Published Online: 14 March 2013
...Fahad Javaid Siddiqui; Narayanaswamy Venketasubramanian; Edwin Shih-Yen Chan; Christopher Chen Background: Subsequent to a pooled analysis of 2 trials, several more studies have been published assessing the benefit of MLC601 in stroke patients. Hence, it is timely to conduct an updated meta...
Journal Articles
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (2000) 10 (2): 147–150.
Published Online: 18 February 2000
...E.L.L.M. De Schryver The ESPRIT trial addresses the problem that aspirin, the standard therapy for secondary prevention of vascular complications after a transient ischaemic attack (TIA) or ischaemic stroke of arterial origin, reduces the risk of serious vascular events by only about 13...
Journal Articles
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (1994) 4 (3): 194–196.
Published Online: 18 May 1994
...J.W. Norris; L.H. LeBrun; B.A. Anderson Numerous animal studies have indicated a beneficial effect of nimodipine in experimental cerebral infarction when the drug is given just before or within 1 h of the cerebral ischaemia. We performed a randomised, placebo-controlled trial, starting within 48 h...